| Aducanumab for Alzheimer’s disease? S Walsh, R Merrick, R Milne, C Brayne bmj 374, 2021 | 192 | 2021 |
| Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: Combined data from 13 community-based or population-based autopsy cohorts PT Nelson, C Brayne, ME Flanagan, EL Abner, S Agrawal, J Attems, ... Acta neuropathologica 144 (1), 27-44, 2022 | 85 | 2022 |
| LATE-NC staging in routine neuropathologic diagnosis: an update PT Nelson, EB Lee, MD Cykowski, I Alafuzoff, K Arfanakis, J Attems, ... Acta neuropathologica 145 (2), 159-173, 2023 | 53 | 2023 |
| Lecanemab for Alzheimer’s disease S Walsh, R Merrick, E Richard, S Nurock, C Brayne bmj 379, 2022 | 43 | 2022 |
| The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia E Nichols, R Merrick, SI Hay, D Himali, JJ Himali, S Hunter, HAD Keage, ... The Lancet Healthy Longevity 4 (3), e115-e125, 2023 | 27 | 2023 |
| The relevance of social and commercial determinants for neurological health S Walsh, R Merrick, C Brayne The Lancet Neurology 21 (12), 1151-1160, 2022 | 23 | 2022 |
| How selection over time contributes to the inconsistency of the association between sex/gender and cognitive decline across cognitive aging cohorts A Rouanet, J Avila-Rieger, A Dugravot, J Lespinasse, R Stuckwisch, ... American Journal of Epidemiology 191 (3), 441-452, 2022 | 13 | 2022 |
| Aducanumab for Alzheimer’s disease? BMJ 374, n1682 S Walsh, R Merrick, R Milne, C Brayne | 8 | 2021 |
| Evaluation of clinical benefits of treatments for Alzheimer's disease KY Liu, S Walsh, C Brayne, R Merrick, E Richard, R Howard The Lancet Healthy Longevity 4 (11), e645-e651, 2023 | 4 | 2023 |
| Winter is coming, and it is going to be tough: COVID-19 and winter preparedness R Merrick, S Walsh, J Ford, J Morling, ACK Lee Public Health 187, A1-A2, 2020 | 3 | 2020 |
| Insights into the pathological basis of dementia from population‐based neuropathology studies SB Wharton, JE Simpson, PG Ince, CD Richardson, R Merrick, ... Neuropathology and Applied Neurobiology 49 (4), e12923, 2023 | 2 | 2023 |
| Harmonization of neuropathology measures and characterization of neuropathological burden across population‐based autopsy samples E Nichols, R Merrick, S Wharton, FE Matthews, C Brayne, T Vos Alzheimer's & Dementia 18, e059207, 2022 | 1 | 2022 |
| Time trends in neuropathology give clues to dementia risk reduction R Merrick, FE Matthews Nature Reviews Neurology 19 (7), 389-390, 2023 | | 2023 |
| Action needed on social and commercial determinants of neurological health–Authors' reply S Walsh, R Merrick, C Brayne The Lancet Neurology 22 (4), 294, 2023 | | 2023 |
| Suffolk Dementia Needs Assessment: Update A Crispe, R Merrick | | 2016 |
| It’s never too LATE to learn more about dementia R Merrick, R is a final year PhD | | |
